Atopic dermatitis affects up to 10% of adults globally, with higher prevalence and severity among people with skin of colour. This is a critical consideration for Canada’s diverse patient population. Yet, many patients remain symptomatic despite topical prescription therapy, often due to suboptimal foundational skincare rather than inadequate pharmacotherapy. This case-based program equips primary care clinicians with practical strategies to optimize AD management through evidence-based adjunctive skincare, emphasizing the role of ceramide-containing formulations in restoring skin barrier function across diverse skin types.
Participants will explore AD pathogenesis, review the clinical evidence for ceramide-based therapies, and develop practical counseling skills they can immediately apply in practice to improve patient outcomes and quality of life.
This program has received financial support from L’Oréal in the form of an unrestricted educational grant.